Trial Profile
A Multi-Center, Randomized, Double-Blind Phase III Study of the Efficacy and Safety of the Misoprostol Vaginal Insert Compared to Cervidil for Women Requiring Cervical Ripening and Induction of Labor (The MVP Study).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Misoprostol (Primary) ; Dinoprostone
- Indications Labour disorders; Labour induction
- Focus Therapeutic Use
- Acronyms MVP
- 01 Oct 2008 Results have been published in Obstetrics and Gynecology.
- 10 Sep 2007 Status changed from recruiting to completed.
- 12 Jun 2007 New trial record.